The board approved Rhopressa (netarsudil ophthalmic solution) 0.02% for addition to Rule 64B13-18.002. Effective January 25, 2019, Licensees are now permitted to prescribe Rhopressa.
Announcing MQA’s FY 2024-25
Performance Report for Quarter Two Continue reading
January 24, 2025, Board Meeting Update: Due to unsafe travel conditions for several required attendees, this meeting of the Florida Board of Optometry is being canceled. The date, time, and location of the rescheduled meeting will be posted as soon … Continue reading
